2015 World STI & HIV Congress and Australasian HIV&AIDS Conference
 

Friday 18 September 2015

This page primarily shows the powerpoint slides and a limited selection of videos from the conference.  Please be aware that only the powerpoints from those speakers who gave permission are available below. Please view the conference program here.  

 
7.00am - 8.20am
Case Presentation Breakfast
Bianca Parsons
Case Study: A Genital Bump (019)


 

10.30am - 12.30pm 
Theme B - Co-morbidities
Wasana Prasitsuebsai
Changes in Renal Laboratory Parameters and Bone Mineral Density in Treatment-Naïve HIV-1-Infected Adolescents Initiating Therapy with INSTI-Based Single-Tablet Regimens Containing Tenofovir Alafenamide (TAF) or Tenofovir Disoproxil Fumarate (TDF) (695)

Shanti Narayanasamy
HIV Positive Outpatients With Treated Hypertension: Failure To Achieve Blood Pressure Targets (642)

Truc Thanh Thai
Prevalence and Correlates of HIV-Associated Dementia in HIV Outpatients in Ho Chi Minh City, Vietnam (443)

Janine Trevillyan
Management guidelines for HIV-related Co-morbidities Result in Increased Screening but no Change in Primary Prevention Implementation (106)

Clara Brown
Australian HIV/Hepatitis C Co-Infected Patients Fall Behind HIV Mono-Infected Patients in move towards Early HIV Treatment Initiation




10.30am - 12.30pm
 Theme D - HIV and Migration

John-Paul Sanggaran & Bridget Haire

Asylum seekers, immigration detention are HIV: What are the issues?
Kathy Petoumeno 
ARV access for Medicare Ineligible and the ATRAS study


Video Presentation

Christopher Lemoh      
Moving targets


Video Presentation


 
1.30pm - 3.00pm
Theme A - Infection of CCR5+ CD4 T cells and its consequences
Michael Roche
Molecular gymnastics: HIV-1 R5 resistance to CCR5 antagonists and impact on viral phenotype


 
1.30pm - 3.00pm
Theme B - ARV Guidelines Session 2: PrEP
Vincent Cornelisse
PrEP in primary care

Mark Bloch
PrEP at the coalface

Edwina Wright
PrEP availability and access options in Australia



 
 
3.30pm - 5.00pm
Theme A - ACH2
Kylie Wagstaff
Development of Nuclear Import Inhibitors as Anti-HIV Agents (533)


3.30pm - 5.00pm Theme B - HIV Populations and Models of Care